The atrial appendage occluder market is on a remarkable growth trajectory, with a projected market size of USD 983.5 million in 2023, expected to surge to USD 8,193.0 million by 2033. This growth is underpinned by a robust CAGR of 23.6% throughout the forecast period.
The left atrial appendage (LAA) is a small, ear-shaped pouch located in the upper left chamber of the heart, specifically the left atrium. While the precise functional significance of the LAA remains unclear, it has become a focal point in patients with arrhythmic cardiovascular conditions, such as atrial fibrillation. In these patients, blood can accumulate in the LAA, increasing the risk of clot formation and subsequent complications such as stroke.
Atrial appendage occluders are innovative medical devices designed to prevent blood clots from forming in the LAA, thereby reducing the risk of stroke in patients with atrial fibrillation. As awareness of the benefits of these devices grows, along with advances in minimally invasive surgical techniques, the market is poised for substantial expansion.
To avoid such difficulties, in addition to oral anticoagulants, an occluder can be used to permanently block off the LAA. Atrial appendage occlusion, which includes inserting a plug into the appendage, is a potential approach for protecting patients’ cardiovascular health.
According to a recent study published in the journal Clinical Medical Insights: Cardiology, atrial fibrillation affects about 2% of the global population, with the disease’s incidence expected to rise fivefold over the next four decades, particularly in the United States due to its growing elderly population.
Atrial Appendage Occluder Market: Drivers and Restraints
The increased number of cardiovascular patients diagnosed with thromboembolism and atrial fibrillation worldwide is driving the global market for Atrial Appendage Occluders. Sedentary lifestyles and accompanying diseases such as diabetes, obesity, and hypertension have further increased demand for such devices, paving the way for market expansion.
However, the restricted usage of LAA occluders in patients at high risk of stroke and bleeding while on anticoagulant medication may limit market expansion. Furthermore, the implantation and removal of the device can result in complications such as tissue erosion, which may necessitate open-heart surgery, restricting market growth. Furthermore, unfavorable laws governing endocardial LAA closure have stifled industry expansion.
Atrial Appendage Occluder Market: Overview
With only a few competitors, the global Atrial Appendage Occluder market is extremely consolidated. According to the World Health Organisation (WHO), over 15 million strokes occur worldwide each year. In 2010, the US spent around $53.9 billion on health care services, medications, and lost work days due to a heart attack.
Ischemic strokes, which occur when blood circulation to the brain is disrupted, account for approximately 87% of all strokes. Stroke is the third leading cause of death and the leading cause of long-term disability. Atrial fibrillation is responsible for around 20% of ischemic strokes.
Atrial Appendage Occluder Market: Region-wise Outlook
North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and the Middle East and Africa are the geographical segments of the Atrial Appendage Occluder Market. The North American market now leads the global industry, owing mostly to its vast elderly population.
Atrial Appendage Occluder Market: Key Players
The key players in the global Atrial Appendage Occluder Market include Appriva Medical Inc., Boston Scientific, St. Jude Medical, SentreHEART Inc, pfm medical ag., Occlutech, W. L. Gore & Associates, Inc., Cardia, Inc. and AtriCure, Inc.
Key Segments Profiled In The Atrial Appendage Occluder Industry Survey
Type of indication:
- Non-valvular Atrial Fibrillation
Procedure of positioning of the device:
- Endocardial
- Epicardial
End user:
- Hospitals
- Clinics
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
